For instance, mutations in the insulin gene (INS) have been shown to cause hyperinsulinemia, hyperproinsulinemia, neonatal diabetes mellitus, MODY10, and autoantibody-negative type 1 diabetes mellitus (DM1) [14]. This evidence concerns the gene INS and hyperproinsulinemia.